小児用ワクチン市場：技術、ワクチン、適応症、エンドユーザー別-2025-2030年の世界予測

小児用ワクチン市場の2023年の市場規模は190億7,000万米ドルで、2024年には212億6,000万米ドルに達すると予測され、CAGR 11.57%で成長し、2030年には410億6,000万米ドルに達すると予測されています。

小児用ワクチン市場は、乳幼児期から思春期までの子供たちの予防接種ニーズを対象とした、幅広い範囲を網羅する市場です。最新の小児用ワクチンは、はしか、おたふくかぜ、風疹、ポリオ、インフルエンザ、水疱瘡など、さまざまな感染症から身を守るように設計されています。これらのワクチンの必要性は、集団免疫を達成し、アウトブレイクを予防するという目的によって強調されます。これらのワクチンは、クリニック、病院、薬局を拠点とする予防接種センターなど、公共および民間のヘルスケア環境で使用され、定期的な予防接種スケジュールと特別な予防接種キャンペーンの両方に対応しています。

市場は主に、予防接種の利点に対する意識の高まり、政府による義務付け、WHOやユニセフなどの組織による世界保健イニシアティブによって牽引されています。ワクチン技術の進歩、官民パートナーシップ、小児の伝染病罹患率の上昇なども後押ししています。さらに、新規ワクチン開発のための研究開発への投資が増加しており、特にmRNA技術の出現によって有利な機会がもたらされています。しかし、市場の成長には、ワクチンへのためらい、サプライチェーンの混乱、市場開拓の高コスト、新規ワクチンの導入を妨げる厳しい規制要件が立ちはだかります。

潜在的な機会を捉えるため、企業は針を使わない技術など送達方法の革新に注力し、ワクチン保護期間の延長を模索すべきです。デジタルヘルスの統合を重視することは、ワクチンの追跡調査と接種効率の向上に役立ちます。課題に対処し、誤った情報に対抗するための効果的なコミュニケーション戦略を育成し、新興市場でのアクセス拡大のための協力関係を促進することで、市場拡大を促進することができます。混合ワクチンの継続的な調査とコールドチェーンロジスティクスの改善は、ビジネス成長のための極めて重要な分野です。市場力学はダイナミックであり、急速な技術進化、規制当局の監視、業務の複雑性を特徴としているが、これらの課題を巧みに乗り切る企業にとっては、革新と拡大の大きな可能性を提供しています。

市場力学：急速に進化する小児用ワクチン市場の主要市場インサイトを公開

小児用ワクチン市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 小児人口における感染症の流行増加
  • 重篤な疾患の予防や他者への感染防止など、予防接種のメリット
  • 小児用ワクチンの使用に対する政府の介入
• 市場抑制要因
  • 予防接種の義務化の欠如
  • 小児用ワクチンに関連するわずかな副作用
• 市場機会
  • 強力な後期パイプラインと新薬承認
  • 乳幼児の予防接種に使用されるワクチンの定期接種化
• 市場の課題
  • 統一されたリコールやリマインダーシステムがなく、スタッフが不足している

ポーターの5つの力：小児用ワクチン市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：小児用ワクチン市場における外部からの影響の把握

外部マクロ環境要因は、小児用ワクチン市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析小児用ワクチン市場における競合情勢の把握

小児用ワクチン市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス小児用ワクチン市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、小児用ワクチン市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨小児用ワクチン市場における成功への道筋を描く

小児用ワクチン市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 小児人口における感染症の蔓延の増加
    • 予防接種の利点は、深刻な病気の予防や他人への病気の蔓延の防止などです。
    • 小児用ワクチンの使用に対する政府の介入
  • 抑制要因
    • 義務的ワクチン接種の実施不足
    • 小児用ワクチンに関連する軽微な副作用
  • 機会
    • 強力な後期パイプラインと新薬承認
    • 乳幼児の予防接種に使用される定期ワクチン
  • 課題
    • 統一されたリコールやリマインダーシステムがなく、人員が不足している
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 小児用ワクチン市場：技術別

• 弱毒生ウイルス
• 活用形
• 不活化ウイルス
• 多糖類
• 組み換え
• サブユニット
• トキソイド

第7章 小児用ワクチン市場ワクチン

• 一価
• 多価

第8章 小児用ワクチン市場適応症別

• インフルエンザ菌B型
• 肝炎
• ヒトパピローマウイルス
• 麻疹
• 髄膜炎A
• おたふく風邪
• 肺炎球菌感染症
• ポリオ
• ロタウイルス
• 風疹
• 破傷風
• 黄熱病

第9章 小児用ワクチン市場：エンドユーザー別

• 病院
• 小児科クリニック
• 調査組織

第10章 南北アメリカの小児用ワクチン市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の小児用ワクチン市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの小児用ワクチン市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• AstraZeneca PLC
• Bavarian Nordic A/S
• CSL Limited
• Eli Lilly and Company
• GlaxoSmithKline PLC
• Indian Immunologicals Ltd.
• Johnson & Johnson Services, Inc.
• Merck & Co., Inc.
• Mitsubishi Chemical Corporation
• Novartis AG
• Pfizer Inc.
• Sanofi S.A.
• Serum Institute of India Pvt. Ltd.
• SINOVAC Biotech Ltd.
• Zoetis Inc.

LIST OF FIGURES

• FIGURE 1. PEDIATRIC VACCINES MARKET RESEARCH PROCESS
• FIGURE 2. PEDIATRIC VACCINES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL PEDIATRIC VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. PEDIATRIC VACCINES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. PEDIATRIC VACCINES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. PEDIATRIC VACCINES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL PEDIATRIC VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. PEDIATRIC VACCINES MARKET DYNAMICS
• TABLE 7. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY ATTENUATED LIVE VIRUSES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY CONJUGATES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY INACTIVATED VIRUSES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY POLYSACCHARIDES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY SUBUNITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TOXOIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MONOVALENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MULTIVALENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HAEMOPHILUS INFLUENZAE TYPE B, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HEPATITIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HUMAN PAPILLOMAVIRUS , BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MEASLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MENINGITIS A, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MUMPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY PNEUMOCOCCAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY POLIO, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY ROTAVIRUSES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY RUBELLA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TETANUS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY YELLOW FEVER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY PEDIATRIC CLINIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY RESEARCH ORGANIZATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 48. CANADA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 49. CANADA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 50. CANADA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 51. CANADA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 55. MEXICO PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 69. AUSTRALIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 70. CHINA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 71. CHINA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 72. CHINA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 73. CHINA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 74. INDIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 75. INDIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 76. INDIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 77. INDIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 78. INDONESIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 79. INDONESIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 82. JAPAN PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 83. JAPAN PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 84. JAPAN PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 86. MALAYSIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 87. MALAYSIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 88. MALAYSIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 89. MALAYSIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 90. PHILIPPINES PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 91. PHILIPPINES PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 92. PHILIPPINES PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 93. PHILIPPINES PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 94. SINGAPORE PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 95. SINGAPORE PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 96. SINGAPORE PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 97. SINGAPORE PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 98. SOUTH KOREA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 99. SOUTH KOREA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 100. SOUTH KOREA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 101. SOUTH KOREA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 102. TAIWAN PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 103. TAIWAN PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 104. TAIWAN PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 105. TAIWAN PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 106. THAILAND PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 107. THAILAND PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 108. THAILAND PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 109. THAILAND PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 110. VIETNAM PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 111. VIETNAM PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 112. VIETNAM PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 113. VIETNAM PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 114. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 115. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 116. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 117. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 118. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 119. DENMARK PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 120. DENMARK PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 121. DENMARK PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 122. DENMARK PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 123. EGYPT PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 124. EGYPT PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 125. EGYPT PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 126. EGYPT PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 127. FINLAND PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 128. FINLAND PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 129. FINLAND PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 130. FINLAND PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 131. FRANCE PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 132. FRANCE PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 133. FRANCE PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 134. FRANCE PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 135. GERMANY PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 136. GERMANY PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 137. GERMANY PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 138. GERMANY PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 139. ISRAEL PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 140. ISRAEL PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 141. ISRAEL PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 142. ISRAEL PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 143. ITALY PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 144. ITALY PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 145. ITALY PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 146. ITALY PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 147. NETHERLANDS PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 148. NETHERLANDS PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 149. NETHERLANDS PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 150. NETHERLANDS PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 151. NIGERIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 152. NIGERIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 153. NIGERIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 154. NIGERIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 155. NORWAY PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 156. NORWAY PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 157. NORWAY PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 158. NORWAY PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 159. POLAND PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 160. POLAND PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 161. POLAND PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 162. POLAND PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 163. QATAR PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 164. QATAR PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 165. QATAR PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 166. QATAR PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 167. RUSSIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 168. RUSSIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 169. RUSSIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 170. RUSSIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 171. SAUDI ARABIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 172. SAUDI ARABIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 173. SAUDI ARABIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 174. SAUDI ARABIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 175. SOUTH AFRICA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 176. SOUTH AFRICA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 177. SOUTH AFRICA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 178. SOUTH AFRICA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 179. SPAIN PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 180. SPAIN PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 181. SPAIN PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 182. SPAIN PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 183. SWEDEN PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 184. SWEDEN PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 185. SWEDEN PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 186. SWEDEN PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 187. SWITZERLAND PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 188. SWITZERLAND PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 189. SWITZERLAND PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 190. SWITZERLAND PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 191. TURKEY PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 192. TURKEY PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 193. TURKEY PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 194. TURKEY PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 195. UNITED ARAB EMIRATES PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 196. UNITED ARAB EMIRATES PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 197. UNITED ARAB EMIRATES PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 198. UNITED ARAB EMIRATES PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 199. UNITED KINGDOM PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 200. UNITED KINGDOM PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 201. UNITED KINGDOM PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 202. UNITED KINGDOM PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 203. PEDIATRIC VACCINES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 204. PEDIATRIC VACCINES MARKET, FPNV POSITIONING MATRIX, 2023

The Pediatric Vaccines Market was valued at USD 19.07 billion in 2023, expected to reach USD 21.26 billion in 2024, and is projected to grow at a CAGR of 11.57%, to USD 41.06 billion by 2030.

The pediatric vaccines market encompasses a broad scope, targeting the immunization needs of children from infancy through adolescence. Modern pediatric vaccines are designed to protect against a variety of infectious diseases, including measles, mumps, rubella, polio, influenza, and chickenpox, among others. The necessity of these vaccines is underscored by the objective of achieving herd immunity and preventing outbreaks, which is critical for public health. They find applications in public and private healthcare settings, including clinics, hospitals, and pharmacy-based immunization centers, catering to both routine immunization schedules and special vaccination campaigns.

The market is primarily driven by increased awareness of the benefits of immunization, government mandates, and global health initiatives from organizations such as WHO and UNICEF. Boosting factors include advancements in vaccine technology, public-private partnerships, and rising incidence of contagious diseases in children. Additionally, growing investments in R&D efforts for novel vaccine development provide lucrative opportunities, especially with the emergence of mRNA technologies. However, market growth is challenged by vaccine hesitancy, supply chain disruptions, high costs of development, and stringent regulatory requirements, which can impede the introduction of new vaccines.

To seize potential opportunities, companies should focus on innovations in delivery methods, such as needle-free technologies, and explore the extension of vaccine protection durations. Emphasizing digital health integration can help enhance vaccine tracking and coverage efficiency. Addressing challenges, fostering effective communication strategies to combat misinformation, and fostering collaborations for expanding access in emerging markets can facilitate market expansion. Continued research into combination vaccines and better cold chain logistics are pivotal areas for business growth. The pediatric vaccines market is dynamic, characterized by rapid technological evolution, regulatory scrutiny, and operational complexities, yet it offers vast potential for innovation and expansion for firms that navigate these challenges adeptly.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pediatric Vaccines Market

The Pediatric Vaccines Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of infectious diseases in the pediatric population
  • Benefits of immunizations like protection from serious diseases prevention and the spread of those diseases to others
  • Government intervention for the use of pediatric vaccines
• Market Restraints
  • Lack of implementation of mandatory vaccination
  • Slight-side effects associated with pediatric vaccines
• Market Opportunities
  • Strong late-stage pipeline and new drug approvals
  • Routinized vaccines used in immunization of infants and children
• Market Challenges
  • No uniform recall or reminder system and staff shortages

Porter's Five Forces: A Strategic Tool for Navigating the Pediatric Vaccines Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pediatric Vaccines Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pediatric Vaccines Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pediatric Vaccines Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pediatric Vaccines Market

A detailed market share analysis in the Pediatric Vaccines Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pediatric Vaccines Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pediatric Vaccines Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pediatric Vaccines Market

A strategic analysis of the Pediatric Vaccines Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pediatric Vaccines Market, highlighting leading vendors and their innovative profiles. These include AstraZeneca PLC, Bavarian Nordic A/S, CSL Limited, Eli Lilly and Company, GlaxoSmithKline PLC, Indian Immunologicals Ltd., Johnson & Johnson Services, Inc., Merck & Co., Inc., Mitsubishi Chemical Corporation, Novartis AG, Pfizer Inc., Sanofi S.A., Serum Institute of India Pvt. Ltd., SINOVAC Biotech Ltd., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Pediatric Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Technology, market is studied across Attenuated Live Viruses, Conjugates, Inactivated Viruses, Polysaccharides, Recombinant, Subunits, and Toxoids.
• Based on Vaccine, market is studied across Monovalent and Multivalent.
• Based on Indication, market is studied across Haemophilus Influenzae Type B, Hepatitis, Human Papillomavirus , Measles, Meningitis A, Mumps, Pneumococcal Diseases, Polio, Rotaviruses, Rubella, Tetanus, and Yellow Fever.
• Based on End User, market is studied across Hospital, Pediatric Clinic, and Research Organization.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of infectious diseases in the pediatric population
    • 5.1.1.2. Benefits of immunizations like protection from serious diseases prevention and the spread of those diseases to others
    • 5.1.1.3. Government intervention for the use of pediatric vaccines
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of implementation of mandatory vaccination
    • 5.1.2.2. Slight-side effects associated with pediatric vaccines
  • 5.1.3. Opportunities
    • 5.1.3.1. Strong late-stage pipeline and new drug approvals
    • 5.1.3.2. Routinized vaccines used in immunization of infants and children
  • 5.1.4. Challenges
    • 5.1.4.1. No uniform recall or reminder system and staff shortages
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Pediatric Vaccines Market, by Technology

• 6.1. Introduction
• 6.2. Attenuated Live Viruses
• 6.3. Conjugates
• 6.4. Inactivated Viruses
• 6.5. Polysaccharides
• 6.6. Recombinant
• 6.7. Subunits
• 6.8. Toxoids

7. Pediatric Vaccines Market, by Vaccine

• 7.1. Introduction
• 7.2. Monovalent
• 7.3. Multivalent

8. Pediatric Vaccines Market, by Indication

• 8.1. Introduction
• 8.2. Haemophilus Influenzae Type B
• 8.3. Hepatitis
• 8.4. Human Papillomavirus
• 8.5. Measles
• 8.6. Meningitis A
• 8.7. Mumps
• 8.8. Pneumococcal Diseases
• 8.9. Polio
• 8.10. Rotaviruses
• 8.11. Rubella
• 8.12. Tetanus
• 8.13. Yellow Fever

9. Pediatric Vaccines Market, by End User

• 9.1. Introduction
• 9.2. Hospital
• 9.3. Pediatric Clinic
• 9.4. Research Organization

10. Americas Pediatric Vaccines Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Pediatric Vaccines Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Pediatric Vaccines Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AstraZeneca PLC
• 2. Bavarian Nordic A/S
• 3. CSL Limited
• 4. Eli Lilly and Company
• 5. GlaxoSmithKline PLC
• 6. Indian Immunologicals Ltd.
• 7. Johnson & Johnson Services, Inc.
• 8. Merck & Co., Inc.
• 9. Mitsubishi Chemical Corporation
• 10. Novartis AG
• 11. Pfizer Inc.
• 12. Sanofi S.A.
• 13. Serum Institute of India Pvt. Ltd.
• 14. SINOVAC Biotech Ltd.
• 15. Zoetis Inc.